MeSH tree: F03.900.647
A new position paper from researchers at the University of Aberdeen warns that opioid use disorder in the U.K. is a "large and probably underestimated" problem, and that without urgent action, opioid addiction and opioid-related ...
Jul 30, 2026
0
4
A study co-led by investigators at Mass General Brigham shows that mobile addiction services can be implemented across multiple organizations and communities to bring addiction treatment, harm reduction services and basic ...
Jul 29, 2026
0
6
Severe flooding may contribute to higher mortality rates from opioid use in rural Appalachia, according to a study by researchers at Penn State. The findings—published in the Proceedings of the National Academy of Sciences—are ...
Jul 20, 2026
0
5
From headlines and social media, psychedelic therapies, cannabis use and GLP-1 medications have seemingly become commonplace overnight, but the science underlying these treatments and the pathway to drug approval are often ...
Jul 20, 2026
0
6
The official sum of opioid-related settlements between U.S. state and local governments and major pharmaceutical opioid manufacturers, marketers, distributors and retailers recently reached $58.58 billion. Stark statistics ...
Jul 16, 2026
0
14
Although opioids remain indispensable for pain relief in patients with advanced cancer, their use frequently results in OIC, which can substantially reduce quality of life and, in some cases, compromise the continuation of ...
Jul 11, 2026
0
5
There has been a substantial increase in recent years in the use of a form of primary medication to treat opioid use disorder, according to a Rutgers Health study published in Health Affairs. Researchers have also noted sharp ...
Jul 7, 2026
0
3
At two clinics in Oslo and Bergen, a small group of patients have been given a new treatment option for opioid addiction. Twice daily, they receive pharmaceutical heroin as medication, administered under close supervision ...
Jul 7, 2026
0
7
Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according to a new national analysis published in the Journal of the American College of Surgeons. The study ...
Jul 1, 2026
0
1
The U.S. Food and Drug Administration has approved another over-the-counter intranasal naloxone product, Rextovy (naloxone hydrochloride), for the emergency treatment of opioid overdose. The nonprescription approval was granted ...
Jun 19, 2026
0
8
